Commentary on: Return of the cycad hypothesis - Does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?

Neuropathology and Applied Neurobiology

Volumn 32, Issue 3, 2006, Pages 341-343

  Wilson, Jason ^a   Shaw, Christopher A ^a  

^a VCH Research Pavillion   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3 METHYLAMINOPROPIONIC ACID; APOLIPOPROTEIN E; METHYLAZOXYMETHANOL;

ALLELE; AMYOTROPHIC LATERAL SCLEROSIS; DEGENERATIVE DISEASE; GENETIC SUSCEPTIBILITY; GUAM; LETTER; NEUROLOGIC DISEASE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CYCAS; HUMANS; PARKINSONIAN DISORDERS; PLANTS, TOXIC;

EID: 33646110091     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2006.00718.x     Document Type: Letter

References (31)

1. Ince PG Codd GA. Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health? Neuropathol Appl Neurobiol 2005 31 345 53
2. Spencer PS Nunn PB Hugon J Ludolph AC Ross SM Roy DN Robertson RC. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science 1987 237 517 22
3. Perry TL Bergeron C Biro AJ Hansen S. Beta-N-methylamino-L-alanine. Chronic oral administration is not neurotoxic to mice. J Neurol Sci 1989 94 173 80
4. Schulz JD Cruz-Aguado R Hawkes EL Singh S Shaw CA. Comparative study of the roles of novel cycad toxins versus BMAA in the etiology of ALS-PDC. Program No. 332.8. 2005 Abstract Viewer/Itinerary Planner. Washington, DC Society for Neuroscience 2005. Online http://sfn.scholarone.com/itin2005/
5. Duncan MW Steele JC Kopin IJ Markey SP. 2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Neurology 1990 40 767 72
6. Wilson JM Khabazian I Wong MC Seyedalikhani A Bains JS Pasqualotto BA Williams DE Andersen RJ Simpson RJ Smith R Craig UK Kurland LT Shaw CA. Behavioral and neurological correlates of ALS-parkinsonism dementia complex in adult mice fed washed cycad flour. Neuromolecular Med 2002 1 207 21
7. Cox PA Sacks OW. Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam. Neurology 2002 58 956 9
8. Shaw CA Wilson JM Cruz-Aguado R Singh S Hawkes EL Lee V Marler T. Cycad-induced neurodegeneration in a mouse model of ALS-PDC. Is the culprit really BMAA or is a novel toxin to blame? Botanical Review 2006 in press )
9. Banack SA Cox PA. Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam. Neurology 2003 61 387 9
10. Cox PA Banack SA Murch SJ. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Proc Natl Acad Sci USA 2003 100 13380 3
11. Murch SJ Cox PA Banack SA. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. Proc Natl Acad Sci USA 2004 101 12228 31
12. Chen KM Craig UK Lee CT Haddock R. Cycad neurotoxin, consumption of flying foxes, and ALS/PDC disease in Guam. Neurology 2002 59 1664 author reply 1664-5
13. Marler T Lee V Shaw CA. Cycad toxins and neurological diseases in Guam: defining theoretical experimental standards for correlating human disease with environmental toxins. Horticultural Sci 2005 40 1598 1606
14. Marler T Lee V Shaw CA. Spatial variation of steryl glucosides in cycas micronesica plants - within and among plant sampling procedures. Horticultural Sci 2005 6 1607 1611
15. Montine TJ Li K Perl DP Galasko D. Lack of beta-methylamino-1-alanine in brain from controls, AD, or Chamorros with PDC. Neurology 2005 65 768 9
16. Oh CH Brownson DM Mabry TJ. Screening for non-protein amino acids in seeds of the Guam cycad, Cycas circinalis, by an improved GC-MS method. Planta Med 1995 61 66 70
17. Pan M Mabry TJ Cao P Moini M. Identification of nonprotein amino acids from cycad seeds as N-ethoxycarbonyl ethyl ester derivatives by positive chemical-ionization gas chromatography-mass spectrometry. J Chromatogr A 1997 787 288 94
18. Khabazian I Bains JS Williams DE Cheung J Wilson JM Pasqualotto BA Pelech SL Andersen RJ Wang YT Liu L Nagai A Kim SU Craig UK Shaw CA. Isolation of various forms of sterol beta-d-glucoside from the seed of Cycas circinalis: neurotoxicity and implications for ALS-parkinsonism dementia complex. J Neurochem 2002 82 516 28
19. Wilson JM Khabazian I Pow DV Craig UK Shaw CA. Decrease in glial glutamate transporter variants and excitatory amino acid receptor down-regulation in a murine model of ALS-PDC. Neuromolecular Med 2003 3 105 18
20. Wilson JM Petrik MS Grant SC Blackband SJ Lai J Shaw CA. Quantitative measurement of neurodegeneration in an ALS-PDC model using MR microscopy. Neuroimage 2004 23 336 43
21. Mahieux F Couderc R Moulignier A Bailleul S Podrabinek N Laudet J. [Isoform 4 of apolipoprotein E and Alzheimer disease. Specificity and clinical study]. Rev Neurol (Paris) 1995 151 231 9
22. Farrer LA Cupples LA Haines JL Hyman B Kukull WA Mayeux R Myers RH Pericak-Vance MA Risch N van Duijn CM. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997 278 1349 56
23. Roses AD. Apolipoprotein E, a gene with complex biological interactions in the aging brain. Neurobiol Dis 1997 4 170 85
24. Bedlack RS Strittmatter WJ Morgenlander JC. Apolipoprotein E and neuromuscular disease: a critical review of the literature. Arch Neurol 2000 57 1561 5
25. Drory VE Birnbaum M Korczyn AD Chapman J. Association of APOE epsilon4 allele with survival in amyotrophic lateral sclerosis. J Neurol Sci 2001 190 17 20
26. Lacomblez L Doppler V Beucler I Costes G Salachas F Raisonnier A Le Forestier N Pradat PF Bruckert E Meininger V. APOE: a potential marker of disease progression in ALS. Neurology 2002 58 1112 14
27. Li YJ Pericak-Vance MA Haines JL Siddique N McKenna-Yasek D Hung WY Sapp P Allen CI Chen W Hosler B Saunders AM Dellefave LM Brown RH Jr Siddique T. Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis. Neurogenetics 2004 5 209 13
28. Wilson JM Petrik MS Moghadasian MH Shaw CA. Examining the interaction of apo E and neurotoxicity on a murine model of ALS-PDC. Can J Physiol Pharmacol 2005 83 131 41
29. Wilson JM Petrik MS Moghadasian MH Grant SC Blackband SJ Krieger C Craig UK Shaw CA. The progression of motor deficits and CNS pathology in ALS-PDC. Program No. 332.5. 2005 Abstract Viewer/Itinerary Planner.
30. Shaw CA Chung JS Wilson JMB Cudkowicz ME Newhall K Braun RH. Is there a causal role of steryl glucoside in ALS? Amytroph Lateral Scler Other Moter Neuron Disord 2005 6 Suppl. 9
31. Kurland LT Mulder DW. Epidemiologic investigations of amyotrophic lateral sclerosis. Neurology 1954 4 355 78